Fadaltran
Fadaltran (BAY 1193397) is an orally active α2C-adrenoreceptor antagonist. Fadaltran can be used for the study of diabetic foot ulcers[1].
Product Specifications
CAS Number
1799809-36-1
Product Name Alternative
BAY 1193397
UNSPSC
12352005
Target
Adrenergic Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Metabolic Disease
Smiles
O=C(N1CCC(N2CC3=C(C=CC=C3)CC2)CC1)C4=CN=C(N(C5)CC65COC6)N=C4
Molecular Formula
C24H29N5O2
Molecular Weight
419.52
References & Citations
[1]Kapsa S, et al. Pharmacokinetics, Safety, and Tolerability of the α2C -Adrenoreceptor Antagonist BAY 1193397 in Healthy Male Subjects. Clin Pharmacol Drug Dev. 2022 Mar;11 (3) :296-308.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
α adrenergic receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
